Multimutational analysis of eleven cystic fibrosis mutations common in the Mediterranean areas

Clinical Chemistry

Volumn 50, Issue 11, 2004, Pages 2155-2157

  Farez Vidal, M Esther ^a   Gómez Llorente, Carolina ^b   Blanco, Sonia ^b   Morales, Pablo ^c   Casals, Teresa ^d   Gómez Capilla, Jose Antonio ^a,b  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CYSTIC FIBROSIS; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SPAIN; ULTRAVIOLET SPECTROPHOTOMETRY;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENETIC SCREENING; HUMANS; MUTATION; SPAIN;

EID: 7044227999     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.032300     Document Type: Article

References (9)

1. Cystic Fibrosis Consortium. Cystic fibrosis mutation database. http://www.genet.sickkids.on.ca/cftr (accessed March 2004).
2. Bobadilla JL, Macek M, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 2002;19:576-606.
3. Casals T, Ramos MD, Gimenez J, Larriba S, Nunes V, Estivill X. High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes. Hum Genet 1997;101:365-70.
4. Gomez-Llorente MA, Suarez A, Gomez-Llorente C, Munoz A, Arauzo M, Antunez A, et al. Analysis of 31 CFTR mutations in 55 families from the South of Spain. Early Hum Dev 2001;65(Suppl):S161-4.
5. Pecheniuk NM, Walsh TP, Marsh NA. DNA technology for the detection of common genetic variants that predispose to thrombophilia. Blood Coagul Fibrinolysis 2000;11:683-700.
6. Farrell PM. Improving the health of patients with cystic fibrosis through newborn screening: Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Adv Pediatr 2000;47:79-115.
7. Waters DL, Wilcken B, Irwing L, Van Asperen P, Mellis C, Simpson JM, et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 1999;80:F1-7.
8. Merelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J 2001;18:306-15.
9. Estivill X, Bancells C, Ramos C. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat 1997;10:135-54.